Yi H. Su
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
The Effect of Heparin-Grafted Chitosan-Cellulose Composite Microspheres on the Removal of Endotoxins and Circulating Histones in a Septic Rabbit Model: An In Vivo Study.
Journal: Biomedicines
Published: February 02, 2026
Zanubrutinib enhances CD19 CAR T killing of B-cell lymphoma by inhibiting BTK phosphorylation, regulating PI3K/AKT/mTOR pathway, and promoting autophagy.
Journal: Blood science (Baltimore, Md.)
Published: September 23, 2025
Correction: Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma.
Journal: Frontiers in immunology
Published: July 28, 2025
Triple stem cell infusion alleviated graft-versus-host disease and improves outcomes in unmanipulated haploidentical hematopoietic stem cell transplantation.
Journal: Cell transplantation
Published: July 25, 2025
Correction: BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Journal: Journal of hematology & oncology
Published: June 03, 2025
Efficacy of erythrocyte apheresis in the management of severe high-altitude deacclimatization syndrome: a retrospective cohort study.
Journal: Frontiers in physiology
Published: May 02, 2025
BCMA/GPRC5D bispecific CAR T-cell therapy for relapsed/refractory multiple myeloma with extramedullary disease: a single-center, single-arm, phase 1 trial.
Journal: Journal of hematology & oncology
Published: April 01, 2025
Case Report: CAR-T therapy for primary cerebellar ALK-negative anaplastic large cell lymphoma.
Journal: Frontiers in immunology
Published: February 03, 2025
A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
Journal: Hematology (Amsterdam, Netherlands)
Published: May 22, 2024
Case report: Donor-derived CLL-1 chimeric antigen receptor T-cell therapy for relapsed/refractory acute myeloid leukemia bridging to allogeneic hematopoietic stem cell transplantation after remission.
Journal: Frontiers in immunology
Published: February 21, 2024
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 28, 2023
Demethylating agents in combination with CD7-targeted CAR-T for the successful treatment of a case with mixed-phenotype acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: A Case Report.
Journal: Frontiers in immunology
Published: July 06, 2023
Last Updated: 09/26/2026